PATENT CLAIM ANALYSIS

Application Number: 16432071
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["424", "094640"]

Abstract:
The present invention provides methods for preventing and/or treating bleeding episodes by administering a single dose of a Factor VIIa equivalent. Preferably, the single dose comprises between about 150 and about 500 ug/kg Factor VIIa equivalent.

Claim (Index 10):
A method for treating a bleeding episode, said method comprising administering to a subject in need of such treatment (i) a first amount of a Factor VIIa equivalent and (ii) a second amount of second coagulant agent, wherein said first and second amounts together comprise an aggregate effective amount for treating said bleeding and said aggregate effective amount is administered in a single dose.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 100.0
- Lexical Diversity: 1.25806
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12127917', '16214996', '10290814', '13987492', '15258908']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7483271984053096
- 35 USC 102 Novelty (BERT): 0.6218653592467553
- Combined Prediction Score: 0.7356810144894541
- Mean Citation Score: 488.54998600000016
- Max Citation Score: 646.3531
- Similarity Product: 502.22699825086

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test